AlphaCentric Advisors »

Source Capital shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Source Capital (SOR) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Source Capital

Tip: Access up to 7 years of quarterly data

All positions including Source Capital held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Source Capital by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $78k 1.7k 45.97

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Vertex Pharmaceuticals Incorporated (VRTX)
Invitation Homes (INVH)
Astrazeneca Ord (AZN)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Axsome Therapeutics (AXSM)
Apogee Therapeutics (APGE)
Euronet Worldwide (EEFT)
Aeva Technologies Com New (AEVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for AlphaCentric Advisors

Top funds holding Source Capital

DKM Wealth Management
D.A. Davidson & Co.
Shaker Financial Services
Diversified Management
Morgan Stanley
Mesirow Financial Investment Management International Equity
First Trust Advisors
Wells Fargo & Company
Hara Capital
Raymond James Financial
Keating Financial Advisory Services
Anchor Investment Management
Invesco
Smith Asset Management
Hennion & Walsh Asset Management

View all funds holding Source Capital